Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

72.27
Delayed Data
As of Apr 29
 -0.07 / -0.10%
Today’s Change
55.00
Today|||52-Week Range
133.62
-33.36%
Year-to-Date
No recent news for Incyte Corp.

Today’s Trading

Previous close72.34
Today’s open71.46
Day’s range70.01 - 73.17
Volume1,353,486
Average volume (3 months)2,098,757
Market cap$13.6B
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+475.38%
Earnings growth (next 5 years)+56.00%
Revenue growth (last year)+47.36%
P/E ratio2,072.6
Price/Sales26.95
Price/Book78.89

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-0.42-0.49%
PRGOPerrigo Company PLC+0.22+0.23%
VRXValeant Pharmaceutic...-1.89-5.36%
MDVNMedivation Inc+1.63+2.90%
Data as of 4:14pm ET, 04/29/2016

Financials

Next reporting dateMay 9, 2016
EPS forecast (this quarter)$0.27
Annual revenue (last year)$753.8M
Annual profit (last year)$6.5M
Net profit margin0.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

Partner Offers

Search for Jobs